PROTAC IRAK4 degrader-1 - HY-129966
Nur noch %1 verfügbar
Catalog #
HY-129966
Ab
587,00 €
PROTAC IRAK4 degrader-1 is a Cereblon-based PROTAC interleukin-1 receptor-associated kinase 4 (IRAK4) degrader extracted from patent US20190192668A1 Compound I-210, makes 20-50%, and >50% IRAK4 degradation at 0.01, 0.1, and 1 μM in OCI-LY-10 cells, respectively[1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-129966/PROTAC-IRAK4-degrader-1-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Blue Ice |
| Application | Cancer-Kinase/protease |
| CAS | 2360533-90-8 |
| Storage | -20°C (Powder, sealed storage, away from moisture) |
| MWT | 904.85 |
| Solubility | DMSO : 180 mg/mL (ultrasonic) |
| Clinical Information | No Development Reported |
| Target | IRAK;PROTACs |
| Application: | Cancer-Kinase/protease |
|---|